🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
2.560
-0.160 (-5.88%)
At close: Nov 20, 2026, 4:00 PM EST
2.600
+0.040 (1.56%)
After-hours: Nov 20, 2026, 7:33 PM EST

Wave Life Sciences Stock Forecast

WVE's stock price has decreased by -62.79% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 21 analysts polled by S&P Global, Wave Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $16.63. The average 1-year stock price forecast is 549.61% higher than the current stock price, while the lowest is $10 (+290.62%) and the highest is $44 (+1,618.75%).

Price Target: $16.63 (+549.61%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$10$16.63$14$44
Change+290.62%+549.61%+446.88%+1618.8%

Analyst Ratings

The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy141414141717
Buy222222
Hold000222
Sell000000
Strong Sell000000
Total161616182121

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$13
BuyMaintains$13+407.81%Nov 17, 2026
Citi
Citi
Buy
Maintains
$19 → $15
BuyMaintains$19 → $15+485.94%Nov 12, 2026
B. Riley Securities
B. Riley Securities
Buy
Maintains
$22 → $18
BuyMaintains$22 → $18+603.13%Nov 9, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$44
BuyMaintains$44+1,618.75%Nov 5, 2026
Wedbush
Wedbush
Buy
Maintains
$12
BuyMaintains$12+368.75%Nov 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
63.67M
from 42.73M
Increased by 49.01%
Revenue Next Year
36.92M
from 63.67M
Decreased by -42.02%
EPS This Year
-1.08
from -1.21
EPS Next Year
-1.19
from -1.08
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
40.96M3.65M113.31M108.30M42.73M63.67M
Revenue Growth
104.03%-91.09%3,005.10%-4.42%-60.55%49.01%
Operating Income
-127.02M-162.72M-68.00M-110.40M-215.38M-240.16M
Net Income
-122.25M-161.82M-57.51M-97.01M-204.38M-224.86M
EPS
-----1.21-1.08
Free Cash Flow
-----188.21M-194.20M
No. Analysts
-----20
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High77.7M
Avg63.7M
Low53.7M

Revenue Growth

Revenue Growth202620272028
High
81.8%
Avg
49.0%
Low
25.6%

EPS Forecast

EPS202620272028
High-0.87
Avg-1.08
Low-1.15

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-